Trump Move Could Send Seniors Fleeing to Medicare Advantage

The Trump administration is ending a program early that kept Medicare prescription drug costs low. Experts say this could push more seniors into Medicare Advantage plans. The program, known as the Medicare Part D premium stabilization, had been holding down monthly premiums for standalone drug plans. Without it, those premiums are expected to rise sharply. Medicare Advantage plans, which combine hospital, medical, and often drug coverage in one private plan, may become a cheaper alternative for many beneficiaries. The shift could mean fewer seniors stick with traditional Medicare and a standalone Part D drug plan. The decision takes effect immediately, leaving millions of seniors facing higher drug plan costs in the coming months.